Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
9:00pm BST
Change (% chg)

$-0.34 (-15.89%)
Prev Close
$2.14
Open
$2.06
Day's High
$2.06
Day's Low
$1.77
Volume
11,540
Avg. Vol
8,809
52-wk High
$3.91
52-wk Low
$1.58

Summary

Name Age Since Current Position

Shlomo Shalev Spokone

55 2015 Chairman of the Board

Joshua Levine

50 2013 Chief Executive Officer

Ronen Twito

41 2013 Deputy Chief Executive Officer, Chief Financial Officer

Moshe Mittelman

62 2010 Chief Medical Officer

Daphna Paran

2016 Medical Director

Alexander Rabinovich

2017 Director

Dafna Cohen

46 2009 External Director

Jaron Diament

48 2009 Non-Executive Director

Garth Russell

IR Contact Officer

Biographies

Name Description

Shlomo Shalev Spokone

Mr. Shlomo Shalev Spokone has been appointed Interim Chairman of the Board at X T L Biopharmaceuticals Ltd. effective August 31, 2015. Until this date, he served as Director at the Company since December 2014. His work experience includes the following roles: Chairman of the Board of Micronet, Board Member at OphirOptronics, Arel Communications and PowerDsine, Senior Vice President of Investments at Ampal and Israel’s Consul for Economic Affairs and the Economic Advisor to the Director General, Ministry of Industry and Trade. He holds a Bachelors degree in Economics from Ben Gurion University and a MBA degree from University of San Francisco.

Joshua Levine

Ronen Twito

Moshe Mittelman

Daphna Paran

Dr. Daphna Paran has been appointed Medical Director at X T L Biopharmaceuticals Ltd. effective March 9, 2016. Dr. Paran has over 20 years of rheumatology expertise with a focus on lupus. She is a senior lecturer at Tel Aviv University, the head of the lupus clinic, head of the rheumatology day care unit and the deputy head of the Department of Rheumatology at the Tel Aviv Medical Center (Ichilov Hospital). She completed her medical studies at Ben Gurion University, trained in lupus and the antiphospholipid syndrome at the lupus unit, Rayne Institute, St. Thomas' Hospital in London and has published or co-authored over 60 articles in the field of lupus and rheumatology.

Alexander Rabinovich

Mr. Alexander Rabinovich has been appointed Director X T L Biopharmaceuticals Ltd. effective April 27, 2017. He is an Investor at the Company.

Dafna Cohen

Jaron Diament

Garth Russell